PROPERTY, PLANT AND EQUIPMENT 8 8.1 Given the nature of its activities, GenSight Biologics does not SIGNIFICANT EXISTING OR PLANNED PROPERTY, generate any noise pollution. PLANT AND EQUIPMENT Sustainable resources management Effective as of January 1, 2015, we leased office space, consisting of approximately 656 square meters located in Paris, France. The The Company’s activities consume water and raw materials lease for this facility expires on December 31, 2024. notably related to the use of printing paper and electricity in a very standard and limited way, generating an impact on the In addition, pursuant to a lease agreement dated September 6, environment that is deemed very low. 2017, we leased office space consisting of approximately 5,575 square feet located in New York, New York for a term of seven These activities do not generate any significant risks for the years and five months. environment. We believe our current office space is sufficient to meet our needs Greenhouse gas emission in the immediate foreseeable future and we do not expect any additional needs before 2019. In 2017, GenSight Biologics implemented measurement tools to evaluate greenhouse gas emissions related to its business travel, which represent by far the greatest contribution to its emissions. 8.2 In teqCO 2017 2016 ENVIRONMENT AND SUSTAINABLE 2 DEVELOPMENT Airplane 86.72 58.18 Environmental constraints are unlikely to significantly affect Train 0.71 1.13 our activities. However, sustainable development is a priority Although operating international activities, the Company for us. We focus our efforts on cost reduction, energy savings encourages teleconferencing. When business travel is required, and operations that increasingly comply with the principles of the Company favors, wherever possible, travel by train, which has sustainable development. lower carbon dioxide emissions than air travel. However, many partners of the Company are based in the United States (regulatory 8.2.1 CORPORATE SOCIAL RESPONSIBILITY agencies, clinical investigators, investors, industrial partners and Please refer to Section 17.2, “Corporate Social Responsibility” of scientific meetings, etc.), which lowers the opportunities for the Registration Document. reducing carbon dioxide emissions apart from teleconferencing. 8.2.2 ENVIRONMENTAL RESPONSIBILITY 8.2.3 CORPORATE SOCIETAL RESPONSIBILITY In order to evaluate and report its impact on the environment, Territorial, economic and social impact GenSight Biologics has implemented a series of measurement tools. Given the limited number of employees and the activities of the General policy Company, it has no impact on employment, regional development Given the nature of its activities, GenSight Biologics is not subject or on local populations. to any environment-specific certification. The Company did not record any provision for risk related to an environmental matter. Compliance with humane experimental practices on animals Our activities do not include industrial production or distribution, and do not therefore use raw materials. We do not produce GenSight Biologics subcontracts its experimental research significant greenhouse gas emissions. activities on animal models. The Company pays considerable attention to selecting renowned contractors that are certified In this context, the only indicator that is relevant is “business by AAALAC International, a private non-profit organization that travel.” is an international reference in assessing the humane animal Pollution and waste management treatment in experimentation. The activities of the Company do not produce any hazardous Supplier selection criteria and fairness of practices waste. The Contract Manufacturing Organizations, or CMOs, with The Company has introduced a separate col lection policy to which GenSight Biologics works are selected on the basis of their encourage recycling. technological capacity and expertise in executing the requested 104– GENSIGHT BIOLOGICS – 2017 Registration Document